Topics

Eyevensys Company Profile

04:46 EDT 22nd October 2019 | BioPortfolio

Eyevensys is a private clinical stage biotechnology company developing its innovative technology to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic diseases.


News Articles [1 Associated News Articles listed on BioPortfolio]

Eyevensys Presents Initial Data from Phase I/II Trial of Innovative, Non-Viral Gene Therapy for Ocular Diseases at 11th Annual Ophthalmology Innovation Summit

Eyevensys a private, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, this week presented results from part 1 of its phase I/II study for non-infectio...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Eyevensys

Eyevensys is a private clinical stage biotechnology company developing its innovative technology to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophth...

More Information about "Eyevensys" on BioPortfolio

We have published hundreds of Eyevensys news stories on BioPortfolio along with dozens of Eyevensys Clinical Trials and PubMed Articles about Eyevensys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eyevensys Companies in our database. You can also find out about relevant Eyevensys Drugs and Medications on this site too.

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...


Corporate Database Quicklinks



Searches Linking to this Company Record